Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. National Vitamin Company Inc
EIR
•National Vitamin Company Inc•June 9, 2022

National Vitamin Company Inc – FDA EIR, Jun 9, 2022

Record Details

A recent FDA surveillance inspection of National Vitamin Company, Inc. (NVC), an OTC drug manufacturer in Casa Grande, AZ, took place from June 6-9, 2022. The inspection, conducted under compliance program 7356.002 (Drug Manufacturing Inspections), focused on OTC docusate sodium and calcium softgel products. Although no FDA Form 483 was issued, several significant verbal observations were noted and discussed with management. Primary issues identified included inadequate written procedures and records for the maintenance and trending of the purified water system. Concerns were raised regarding process validation, as previous Performance Qualification (PQ) protocols for mixing and encapsulation were approved despite failing to meet target specifications or lacking complete supporting raw data. The firm's cleaning procedure for softgels was deemed deficient, notably lacking a clear definition of 'visibly clean,' which was highlighted by dried material found in a mixing tank. Additional observations included inconsistent reporting of water sampling results and the absence of an original, approved vendor evaluation form for their active pharmaceutical ingredient (API) supplier. To address these findings, NVC is required to implement robust written procedures and comprehensive record-keeping for their water system, clearly define 'visibly clean' within their cleaning protocols, and standardize laboratory reporting formats. Furthermore, the company must review and rectify deficiencies in past PQ protocols to ensure consistent production of safe and effective products, and obtain complete, approved vendor qualification documentation.

Company
National Vitamin Company Inc
Inspection date
June 9, 2022
Product type
drugs
Office
Los Angeles District Office
Person
  • Gavin T. Cua (issuing_officer)
View Company Profile

ID · 7fb0d691-519f-4fac-9788-1ba37cd90786

Violation Codes1
21 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for National Vitamin Company Inc
  • 483 - 2025-12-03December 3, 2025
  • 483 - 2015-12-11December 11, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore National Vitamin Company Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.